EP1492447A1 - Method and system for optically measuring swelling of the nose - Google Patents
Method and system for optically measuring swelling of the noseInfo
- Publication number
- EP1492447A1 EP1492447A1 EP03722269A EP03722269A EP1492447A1 EP 1492447 A1 EP1492447 A1 EP 1492447A1 EP 03722269 A EP03722269 A EP 03722269A EP 03722269 A EP03722269 A EP 03722269A EP 1492447 A1 EP1492447 A1 EP 1492447A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- light
- optical
- nose
- arrangement according
- generating components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000008961 swelling Effects 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000003287 optical effect Effects 0.000 claims abstract description 66
- 238000005259 measurement Methods 0.000 claims description 39
- 210000001331 nose Anatomy 0.000 claims description 37
- 230000005540 biological transmission Effects 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 12
- 230000008033 biological extinction Effects 0.000 claims description 6
- 230000003595 spectral effect Effects 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 5
- 210000003128 head Anatomy 0.000 claims description 4
- 239000004065 semiconductor Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 2
- 210000003928 nasal cavity Anatomy 0.000 claims description 2
- 230000002123 temporal effect Effects 0.000 claims 2
- 230000007613 environmental effect Effects 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000010363 phase shift Effects 0.000 claims 1
- 206010028748 Nasal obstruction Diseases 0.000 abstract description 4
- 238000010276 construction Methods 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 description 26
- 239000013566 allergen Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000012067 mathematical method Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000005225 erectile tissue Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
Definitions
- the invention relates to the fields of medicine and device construction and relates to a method and an arrangement for the optical measurement of swelling of the nose, which can be used, for example, to measure nasal obstruction after allergen provocation.
- allergic rhinitis is diagnosed by taking a symptom score (sneezing, secretion, remote symptoms such as tears in the eyes) and by measuring nasal obstruction after allergen challenge using rhinomanometry (Clement et al .: “Rhinomanometry - a review", ORL J. Otorhinolaryngol. Relat. Spec. 46, 173-91, 1984).
- the disadvantage of rhinomanometry here is that the measurement cannot be carried out during allergen application. With severe nasal obstruction, rhinomanometry is perceived by the patient as very unpleasant. Incorrect measurements in uncooperative patients occur frequently.
- a further possibility for determining the swelling state of the nose and in particular of the nasal mucosa is acoustic rhinometry (Fisher: “Acoustic rhinometry", Clin. Otolaryngol. 22, 307-17, 1997). These measurements have a relatively wide range of results. Adequate Accuracy is only achieved for the front sections of the nose, and none can during the measurement Medication or allergen provocation take place. A continuous measurement is not possible with this method either.
- the object of the invention is to provide a method and an arrangement for the optical measurement of swelling conditions of the nose, with which a largely objective measurement of swelling conditions of the nose is made possible, in particular during the performance of provocation tests.
- the arrangement according to the invention for the optical measurement of swelling states of the nose consists of a basic device with light generating components and light detection components as well as associated transmitter electronics and receiver electronics and controllers. Furthermore, at least one optical connection is realized between the basic device and an optical transmission element, the transmission of the light generated by the light generating components into the optical connection to the transmission element being implemented by optical elements. Furthermore, there is at least one optical connection between an optical receiving element and the light detection components. Outside the basic device there are transmitting and receiving elements, which are arranged on an application part. The application part realizes an arrangement of the transmitting and receiving elements that enables the light emitted by the transmitting elements to pass through the swellable tissue of at least one side of the nose to the receiving element. Furthermore, the application part can be positively applied to at least the upper part of the nose.
- the swelling of the nasal tissue is detected optically.
- the nasal tissue is covered from the outside with a Irradiated light source, which is emitted by a transmitting element and by a detector, a receiving element, the scattered light passing through the tissue is detected either on the same or on the opposite side of the nose.
- the light passes through a number of layers of tissue such as the skin, muscles, mucous membrane, bones, cartilage and the airways.
- Part of the permeated tissue is characterized by swelling ability, in particular the nasal mucosa lying above the bones of the nasal turbinates. In this part of the tissue, there is an increase in blood volume during the swelling due to the inflow of blood into the erectile tissue.
- the inflowing blood is primarily arterial in nature and therefore normally at least 95% saturated with oxygen. Furthermore, in the event of edema possibly associated with the swelling, there is an increase in the volume of tissue water. It is therefore advantageous to carry out the irradiation spectrometrically in order to be able to measure the volume fractions of the oxygenated and deoxygenated hemoglobin and of the tissue water separately and quantitatively. This can be done either by using a white light source and a spectrometer detector (e.g. diode line spectrometer) or by using several light sources with discrete radiation spectra (LEDs, laser diodes).
- a white light source and a spectrometer detector e.g. diode line spectrometer
- LEDs discrete radiation spectra
- An advantage of the arrangement according to the invention is that it is characterized by a non-invasive application from the outside and by simple handling.
- Fig. 2 shows two variants of an application part with active transmit
- FIG. 3 an application part and its fixation on the head and nose
- Fig. 4 a basic device of an arrangement according to the invention
- Fig. 5 is a schematic representation of the nose cross-section, showing the
- FIG. 6 shows a schematic representation of the extinction measured values in the course of a
- the arrangement according to the invention consists at least of a basic device 12 with the transmitter 15 and receiver electronics 16 required for the fulfillment of the measurement task and an application part 1 which is in direct contact with the nasal tissue during the measurement.
- An application part 1 is shown in Fig. 1 a and b. It consists of a clasp-shaped body, the two sides of which can be positively attached to the nostrils.
- the light-emitting element, optical transmitter element 2 is arranged on one side of the application part 1, and the light-receiving element, optical receiver element 3 is arranged on the opposite side.
- These are either designed as discrete radiation sources and detectors, the optical axes of which are oriented in the direction of the tissue (FIG.
- the application part 1 is fixed with the aid of a forehead carrier band 8 attached to the head. This ensures that the application part 1 is firmly positioned on the bridge of the nose during the measurement.
- the application part is connected to the carrier tape 8 via a bracket 10.
- the connection is designed so that an exact positioning of the application part on the bridge of the nose, e.g. B. by a lockable ball joint 9 or a flexible metal hose is possible. Further relevant variants of the arrangement according to the invention can be designed as follows:
- the appliqué part is adhesively attached to the nose; the appliqué part is pressed directly onto the nose using an elastic band or the circumference can be adjusted to the size of the head; the appliqué part is designed as a frame similar to glasses, which sits on the root of the nose and in which the optical transmission and reception elements are pressed against the tissue of the nose by gravity;
- the suppression and / or calibration of extraneous light influences is also important. It is therefore advantageous to use optical filters or to cover the measurement site during the measurement with an opaque cap, which, for. B. can be fixed as a plastic cap with on the carrier tape and if necessary during the examination is folded over the measuring field.
- the basic device 12 shows a basic device 12 with device-internal light generation components 13 and light detection components 14, to which a previously described application part 1 can be connected via the optical connections 6, 7.
- the basic device 12 consists of transmitter electronics 15 for the optical light generating components 13, receiver electronics 16 and a controller 17, to which further devices can be connected via a data interface.
- the transmitter electronics 15 has at its output a plurality of light generating components 13, the light of which is bundled by an optical element 18. The bundled light is introduced into an optical connection 6.
- a light detection component 14, into which light from the optical connection 7 is incident, is connected to the input of the receiver electronics 16.
- a spectrometric measurement is advantageous for the optical measurement of swelling conditions and the differentiation of swelling causes.
- Light sources with a limited spectrum LEDs, semiconductor lasers
- a photodetector that is sufficiently sensitive to the selected spectral range semiconductor photodetector, photomultiplier
- a white light source and a spectrometrically resolving detector can be used.
- the aim of the measurement is the acquisition of light attenuation values (optical density of the tissue) at individual wavelengths of interest over time. This results from the relationship
- ls ( ⁇ , t) denote the light intensity emitted at the transmitting element and lü ( ⁇ , t) denote the light intensity arriving at the receiving element at the wavelength ⁇ and at time t.
- the extinction E ( ⁇ , t) is generally a function of light scattering and light absorption in tissue and thus provides a measurement for the geometric and optical change in the tissue.
- the relationship between blood and tissue water gain can be represented.
- special optical measurement techniques it is possible to determine the scattering and absorption properties of the tissue separately. This requires photon transit time measurements using a high-frequency modulation technique (intensity modulation of the light source (s) and amplitude and phase measurement of the receiver signal) or a pulse laser technique (application of short laser pulses and time-resolved measurement of the receiver signal).
- a high-frequency modulation technique intensity modulation of the light source (s) and amplitude and phase measurement of the receiver signal
- pulse laser technique application of short laser pulses and time-resolved measurement of the receiver signal.
- the application part After preparation of the person to be examined, the application part is fixed on the bridge of the nose near the root of the nose so that the optical transmission and reception elements on the tissue face each other and the optical radiation penetrates as much swellable tissue as possible inside the nose (Fig. 5). Then a photometric signal that is as optimal as possible is set with the aid of manual, automatic or semi-automatic adjustment of source intensity (s) and / or detector sensitivity in a range suitable for the measurement by means of optomechanical, electronic and / or software technology options. The data acquisition is then started manually by the operator. Controlled by the controller 17 internal to the basic unit, there is a repeated sequential switching of the radiation sources by the transmitter electronics 15 and, at the same time, the detection of the detector measured values by the receiver electronics 16.
- FIG. 6 schematically shows absorbance measurements in the course of a swelling.
- the spectral light attenuation values in the unprovoked state represent the baseline of the measurement. If this is recorded in a time window of 1 to 2 minutes, an allergenic substance is administered by atomization into one or both nasal cavities and the time of measurement, e.g. B. recorded by pressing a foot switch at the time of administration tp. With an allergic reaction, swelling of the nasal tissue then begins, which causes a demonstrable increase in the spectral absorbance. 6 shows spectral extinction values, which were standardized at the start time tp for better comprehensibility. At the time t ⁇ , the swelling reaches a steady state at which no further swelling can be detected. The swelling subsides only after a time t »t E -tp. Information that can be used diagnostically can be derived from the time course of the spectral extinction values. These include in particular:
- the increase ⁇ E ( ⁇ ) E ( ⁇ , t E ) -E ( ⁇ , t P ) of the absorbance for a wavelength as a measure of the intensity of the swelling; the extinction value difference ⁇ E ( ⁇ ) - ⁇ E ( ⁇ 2 ) at different wavelengths as a measure of the increase in the volume fractions of different tissue constituents relative to one another; the time difference the reaction from the time of provocation to the final stationary state as a measure of the swelling rate and the shape of the curves E ( ⁇ , t) as an indicator of the physiological course of the swelling.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
Verfahren und Anordnung zur optischen Messung von Schwellungszuständen der NaseMethod and arrangement for the optical measurement of swelling conditions of the nose
Anwendungsgebiet der ErfindungField of application of the invention
Die Erfindung bezieht sich auf die Gebiete der Medizin und des Vorrichtungsbaus und betrifft ein Verfahren und eine Anordnung zur optischen Messung von Schwellungen der Nase, welche beispielsweise zur Messung der nasalen Obstruktion nach Allergenprovokation angewandt werden kann.The invention relates to the fields of medicine and device construction and relates to a method and an arrangement for the optical measurement of swelling of the nose, which can be used, for example, to measure nasal obstruction after allergen provocation.
Stand der TechnikState of the art
Aus medizinischer Sicht besteht ein Erfordernis für eine Objektivierung der Messung des Schwellungszustandes und des Schwellungsverlaufes z. B. bei allergischen Reaktionen, die beispielsweise beim nasalen Provokationstest hervorgerufen werden.From a medical point of view, there is a need for objectification of the measurement of the swelling state and the swelling course z. B. in allergic reactions, which are caused for example in the nasal provocation test.
Die Diagnostik einer allergischen Rhinitis erfolgt heutzutage durch das Erheben eines Symptomscores (Niesreiz, Sekretion, Fernsymptome wie Augentränen) sowie durch die Messung der nasalen Obstruktion nach Allergenprovokation mit Hilfe der Rhinomanometrie (Clement et al.: „Rhinomanometry - a review", ORL J. Otorhinolaryngol. Relat. Spec. 46, 173-91 , 1984). Nachteil der Rhinomanometrie hierbei ist, dass die Messung nicht während der Allergenapplikation durchgeführt werden kann. Bei starker nasaler Obstruktion wird die Rhinomanometrie vom Patienten als sehr unangenehm empfunden. Fehlmessungen bei unkooperativen Patienten treten häufig auf.Nowadays, allergic rhinitis is diagnosed by taking a symptom score (sneezing, secretion, remote symptoms such as tears in the eyes) and by measuring nasal obstruction after allergen challenge using rhinomanometry (Clement et al .: "Rhinomanometry - a review", ORL J. Otorhinolaryngol. Relat. Spec. 46, 173-91, 1984). The disadvantage of rhinomanometry here is that the measurement cannot be carried out during allergen application. With severe nasal obstruction, rhinomanometry is perceived by the patient as very unpleasant. Incorrect measurements in uncooperative patients occur frequently.
Eine weitere Möglichkeit der Bestimmung des Schwellungszustandes der Nase und insbesondere der Nasenschleimhaut ist die akustische Rhinometrie (Fisher: „Acoustic rhinometry", Clin. Otolaryngol. 22, 307-17, 1997). Diese Messungen haben eine relativ grosse Streubreite der Ergebnisse. Eine ausreichende Genauigkeit wird nur für die vorderen Nasenabschnitte erreicht. Während der Messung kann keine Medikamenten- bzw. Allergenprovokation erfolgen. Eine kontinuierliche Messung ist auch bei diesem Verfahren nicht möglich.A further possibility for determining the swelling state of the nose and in particular of the nasal mucosa is acoustic rhinometry (Fisher: "Acoustic rhinometry", Clin. Otolaryngol. 22, 307-17, 1997). These measurements have a relatively wide range of results. Adequate Accuracy is only achieved for the front sections of the nose, and none can during the measurement Medication or allergen provocation take place. A continuous measurement is not possible with this method either.
Weiterhin ist mit beiden Verfahren keine Aussage möglich, ob eine nasale Schwellung auf einer Änderung der MikroZirkulation oder einer Ödembildung beruht.Furthermore, with both methods it is not possible to say whether a nasal swelling is due to a change in the microcirculation or an edema formation.
Darstellung der ErfindungPresentation of the invention
Die Aufgabe der Erfindung besteht darin, ein Verfahren und eine Anordnung zur optischen Messung von Schwellungszuständen der Nase anzugeben, mit dem und der eine weitgehend objektive Messung von Schwellungszuständen der Nase, insbesondere während der Durchführung von Provokationstests, ermöglicht wird.The object of the invention is to provide a method and an arrangement for the optical measurement of swelling conditions of the nose, with which a largely objective measurement of swelling conditions of the nose is made possible, in particular during the performance of provocation tests.
Die Aufgabe wird durch die in den Ansprüchen genannte Erfindung gelöst. Vorteilhafte Ausgestaltungen sind Gegenstand von Unteransprüchen.The object is achieved by the invention mentioned in the claims. Advantageous refinements are the subject of dependent claims.
Die erfindungsgemäße Anordnung zur optischen Messung von Schwellungszuständen der Nase besteht aus einem Grundgerät mit Lichterzeugungskomponenten und Lichtdetektionskomponenten sowie zugeordneter Senderelektronik und Empfängerelektronik und Controller. Weiterhin ist mindestens eine optische Verbindung zwischen dem Grundgerät und einem optischen Sendeelement realisiert, wobei die Weiterleitung des durch die Lichterzeugungskomponenten erzeugten Lichtes in die optische Verbindung zum Sendeelement durch optische Elemente realisiert ist. Es liegt weiterhin mindestens eine optische Verbindung zwischen einem optischen Empfangselement und den Lichtdetektionskomponenten vor. Außerhalb des Grundgerätes befinden sich Sende- und Empfangselemente, die auf einem Applikationsteil angeordnet sind. Das Applikationsteil realisiert dabei eine Anordnung der Sende- und Empfangselemente, die den Durchtritt des vom Sendeelemente ausgesandten Lichtes durch das schwellfähige Gewebe mindestens einer Nasenseite bis zum Empfangselement ermöglicht. Weiterhin ist das Applikationsteil formschlüssig mindestens an den oberen Teil der Nase anlegbar.The arrangement according to the invention for the optical measurement of swelling states of the nose consists of a basic device with light generating components and light detection components as well as associated transmitter electronics and receiver electronics and controllers. Furthermore, at least one optical connection is realized between the basic device and an optical transmission element, the transmission of the light generated by the light generating components into the optical connection to the transmission element being implemented by optical elements. Furthermore, there is at least one optical connection between an optical receiving element and the light detection components. Outside the basic device there are transmitting and receiving elements, which are arranged on an application part. The application part realizes an arrangement of the transmitting and receiving elements that enables the light emitted by the transmitting elements to pass through the swellable tissue of at least one side of the nose to the receiving element. Furthermore, the application part can be positively applied to at least the upper part of the nose.
Mit der erfindungsgemäßen Anordnung wird auf optischem Wege die Schwellung des Nasengewebes erfasst. Dabei wird das Nasengewebe von außen mit einer Lichtquelle bestrahlt, die von einem Sendeelement ausgesandt wird und durch einen Detektor, ein Empfangselement, wird das durch das Gewebe hindurchtretende Streulicht entweder auf der gleichen oder auf der gegenüberliegenden Nasenseite erfasst. Das Licht passiert bei seinem Durchgang durch das Nasengewebe eine Reihe von Gewebeschichten, wie Haut, Muskulatur, Schleimhaut, Knochen, Knorpel, sowie die Luftwege. Ein Teil des durchdrungenen Gewebes zeichnet sich durch Schwellfähigkeit aus, insbesondere die über den Knochen der Nasenmuscheln liegende Nasenschleimhaut. In diesem Teil des Gewebes kommt es im Verlauf der Schwellung zu einer Zunahme des Blutvolumens infolge des Einströmens von Blut in die Schwellkörper. Das zuströmende Blut ist dabei vorrangig arterieller Natur und damit im Normalfall zu mindestens 95% mit Sauerstoff gesättigt. Weiterhin kommt es im Falle einer mit der Schwellung möglicherweise verbundenen Ödembildung zu einer Zunahme des Gewebewasservolumens. Es ist daher vorteilhaft, die Durchstrahlung spektrometrisch durchzuführen, um die Volumenanteile des oxygenierten und deoxygenierten Hämoglobins sowie des Gewebewassers quantitativ getrennt erfassen zu können. Dies kann entweder durch Verwendung einer Weißlichtquelle und eines Spektrometerdetektors (z. B. Diodenzeilenspektrometer) oder durch Verwendung von mehreren Lichtquellen mit diskreten Strahlungsspektren (LEDs, Laserdioden) erfolgen.With the arrangement according to the invention, the swelling of the nasal tissue is detected optically. The nasal tissue is covered from the outside with a Irradiated light source, which is emitted by a transmitting element and by a detector, a receiving element, the scattered light passing through the tissue is detected either on the same or on the opposite side of the nose. As it passes through the nasal tissue, the light passes through a number of layers of tissue such as the skin, muscles, mucous membrane, bones, cartilage and the airways. Part of the permeated tissue is characterized by swelling ability, in particular the nasal mucosa lying above the bones of the nasal turbinates. In this part of the tissue, there is an increase in blood volume during the swelling due to the inflow of blood into the erectile tissue. The inflowing blood is primarily arterial in nature and therefore normally at least 95% saturated with oxygen. Furthermore, in the event of edema possibly associated with the swelling, there is an increase in the volume of tissue water. It is therefore advantageous to carry out the irradiation spectrometrically in order to be able to measure the volume fractions of the oxygenated and deoxygenated hemoglobin and of the tissue water separately and quantitatively. This can be done either by using a white light source and a spectrometer detector (e.g. diode line spectrometer) or by using several light sources with discrete radiation spectra (LEDs, laser diodes).
Da die genannten, an der Schwellung beteiligten Stoffe unterschiedliche optische Absorptionsspektren besitzen, ist eine getrennte Absolut- bzw. Relativbestimmung der Volumenanteile mit entsprechenden mathematischen Methoden möglich. Eine derartige Anordnung ist bis heute nicht beschrieben.Since the substances mentioned, which are involved in the swelling, have different optical absorption spectra, a separate absolute or relative determination of the volume fractions is possible using appropriate mathematical methods. Such an arrangement has not been described to date.
Ein Vorteil der erfindungsgemäßen Anordnung besteht darin, dass sie sich durch eine nichtinvasive Applikation von außen sowie durch eine einfache Handhabung auszeichnet.An advantage of the arrangement according to the invention is that it is characterized by a non-invasive application from the outside and by simple handling.
Beste Wege zur Ausführung der ErfindungBest ways to carry out the invention
Die Erfindung wird nachfolgend an Hand von Ausführungsbeispielen näher erläutert. Die Gestaltung der Anordnung ist dem Untersuchungszweck angepasst. In den Zeichnungen zeigen: Fig. 1 ein Applikationsteil in Vorderansicht (a) und Ansicht von oben (b)The invention is explained in more detail below on the basis of exemplary embodiments. The design of the arrangement is adapted to the purpose of the investigation. The drawings show: 1 is an appliqué part in front view (a) and top view (b)
Fig. 2 zwei Ausführungsvarianten eines Applikationsteils mit aktiven Sende- undFig. 2 shows two variants of an application part with active transmit and
Empfangselementen (a) sowie passiven Sende- und Empfangselementen (b) Fig. 3 ein Applikationsteil und dessen Fixierung an Kopf und Nase Fig. 4 ein Grundgerät einer erfindungsgemäßen Anordnung Fig. 5 eine schematische Darstellung des Nasenquerschnitts, mit Darstellung derReceiving elements (a) and passive transmitting and receiving elements (b) Fig. 3 an application part and its fixation on the head and nose Fig. 4 a basic device of an arrangement according to the invention Fig. 5 is a schematic representation of the nose cross-section, showing the
Lage der optischen Elemente und des Durchstrahlungskanals vor und nach einer Schwellung Fig. 6 eine schematische Darstellung der Extinktionsmesswerte im Verlauf einerPosition of the optical elements and the transmission channel before and after swelling. FIG. 6 shows a schematic representation of the extinction measured values in the course of a
Schwellungswelling
Die erfindungsgemäße Anordnung besteht mindestens aus einem Grundgerät 12 mit der für die Erfüllung der Messaufgabe erforderlichen Sender- 15 und Empfängerelektronik 16 sowie einem Applikationsteil 1 , welches sich während der Messung in direktem Kontakt mit dem Nasengewebe befindet.The arrangement according to the invention consists at least of a basic device 12 with the transmitter 15 and receiver electronics 16 required for the fulfillment of the measurement task and an application part 1 which is in direct contact with the nasal tissue during the measurement.
Ein Applikationsteil 1 ist in Fig. 1 a und b dargestellt. Es besteht aus einem spangenförmigen Grundkörper, deren beide Seiten formschlüssig an die Nasenflügel angelegt werden können. Auf der einen Seite des Applikationsteils 1 ist das lichtabstrahlende Element, optische Sendelement 2, auf der gegenüberliegenden Seite das lichtempfangende Element, optische Empfangselement 3 angeordnet. Diese sind entweder als diskrete Strahlungsquellen und Detektoren ausgeführt, deren optische Achsen in Richtung des Gewebes ausgerichtet sind (Fig. 2a) und die über stromführende Kabel 4 mit dem Grundgerät 12 verbunden sind, oder anderenfalls als optische Verbindungen 6, 7, die die Lichtübertragung vom und zum Grundgerät 12 realisieren und die entweder mit ihren abstrahlenden Flächen senkrecht an das Nasengewebe geführt werden oder durch Anordnung entsprechender optischer Umlenkelemente 5 (Spiegel, Mikroprismen) auf das Gewebe ausgerichtet sind (Fig. 2b).An application part 1 is shown in Fig. 1 a and b. It consists of a clasp-shaped body, the two sides of which can be positively attached to the nostrils. The light-emitting element, optical transmitter element 2, is arranged on one side of the application part 1, and the light-receiving element, optical receiver element 3 is arranged on the opposite side. These are either designed as discrete radiation sources and detectors, the optical axes of which are oriented in the direction of the tissue (FIG. 2a) and which are connected to the basic device 12 via current-carrying cables 4, or else as optical connections 6, 7, which transmit the light from and to the basic device 12 and which are either guided with their radiating surfaces perpendicular to the nasal tissue or are aligned with the tissue by arranging corresponding optical deflection elements 5 (mirrors, microprisms) (FIG. 2b).
Die Fixierung des Applikationsteils 1 erfolgt gemäß Fig. 3 mit Hilfe eines am Kopf angebrachten Stirnträgerbandes 8. Dieses sorgt für eine feste Position des Applikationsteils 1 auf dem Nasenrücken während der Messung. Das Applikationsteil ist über einen Bügel 10 mit dem Trägerband 8 verbunden. Die Verbindung ist so gestaltet, dass eine exakte Positionierung des Applikationsteils auf dem Nasenrücken, z. B. durch ein arretierbares Kugelgelenk 9 oder einen flexiblen Metallschlauch, möglich ist. Weitere diesbezügliche Varianten der erfindungsgemäßen Anordnung können wie folgt gestaltet sein:According to FIG. 3, the application part 1 is fixed with the aid of a forehead carrier band 8 attached to the head. This ensures that the application part 1 is firmly positioned on the bridge of the nose during the measurement. The application part is connected to the carrier tape 8 via a bracket 10. The connection is designed so that an exact positioning of the application part on the bridge of the nose, e.g. B. by a lockable ball joint 9 or a flexible metal hose is possible. Further relevant variants of the arrangement according to the invention can be designed as follows:
- das Applikationsteil ist an der Nase adhäsiv befestigt; das Applikationsteil wird mit Hilfe eines elastischen oder im Umfang auf die Kopfgröße einstellbaren Bandes direkt an die Nase angepresst; das Applikationsteil ist als brillenähnliches Gestell ausgeführt, welches auf der Nasenwurzel sitzt und bei welchem die optischen Sende- und Empfangselemente durch die Schwerkraft am Nasengewebe angedrückt werden;- The appliqué part is adhesively attached to the nose; the appliqué part is pressed directly onto the nose using an elastic band or the circumference can be adjusted to the size of the head; the appliqué part is designed as a frame similar to glasses, which sits on the root of the nose and in which the optical transmission and reception elements are pressed against the tissue of the nose by gravity;
- eine Anordnung, bei der die Sende- und Empfangselemente auf zwei separaten Grundelementen (Pads) angeordnet sind, welche getrennt voneinander auf jeder Nasenseite adhäsiv befestigt werden.- An arrangement in which the transmitting and receiving elements are arranged on two separate basic elements (pads), which are adhesively attached separately on each side of the nose.
Für eine genaue und reproduzierbare Messung ist neben der räumlich stabilen und bewegungsfreien Fixierung des Applikationsteils an der Nase auch die Unterdrückung und/oder Herauskalibrierung von Fremdlichteinflüssen wichtig. Daher ist es vorteilhaft, optische Filter zu verwenden oder den Messort während der Messung durch eine lichtundurchlässige Kappe abzudecken, welche z. B. als Kunststoffkappe mit am Trägerband fixiert sein kann und bei Bedarf während der Untersuchung über das Messfeld geklappt wird.For an accurate and reproducible measurement, in addition to the spatially stable and movement-free fixing of the application part on the nose, the suppression and / or calibration of extraneous light influences is also important. It is therefore advantageous to use optical filters or to cover the measurement site during the measurement with an opaque cap, which, for. B. can be fixed as a plastic cap with on the carrier tape and if necessary during the examination is folded over the measuring field.
In der Fig. 4 ist ein Grundgerät 12 mit geräteinternen Lichterzeugungskomponenten 13 und Lichtdetektionskomponenten 14 dargestellt, an welches über die optischen Verbindungen 6, 7 ein zuvor beschriebenes Applikationsteil 1 anschließbar ist. Das Grundgerät 12 besteht aus einer Senderelektronik 15 für die optischen Lichterzeugungskomponenten 13, einer Empfängerelektronik 16 und einem Controller 17, an den über eine Datenschnittstelle weitere Geräte anschließbar sind. Die Senderelektronik 15 verfügt an ihrem Ausgang über mehrere Lichterzeugungskomponenten 13, deren Licht durch ein optisches Element 18 gebündelt wird. Das gebündelte Licht wird in eine optische Verbindung 6 eingeleitet. Mit dem Eingang der Empfängerelektronik 16 ist eine Lichtdetektionskomponente 14 verbunden, in welche Licht aus der optischen Verbindung 7 einfällt.4 shows a basic device 12 with device-internal light generation components 13 and light detection components 14, to which a previously described application part 1 can be connected via the optical connections 6, 7. The basic device 12 consists of transmitter electronics 15 for the optical light generating components 13, receiver electronics 16 and a controller 17, to which further devices can be connected via a data interface. The transmitter electronics 15 has at its output a plurality of light generating components 13, the light of which is bundled by an optical element 18. The bundled light is introduced into an optical connection 6. A light detection component 14, into which light from the optical connection 7 is incident, is connected to the input of the receiver electronics 16.
Für die optische Messung von Schwellungszuständen und die Differenzierung von Schwellungsursachen ist eine spektrometrische Messung vorteilhaft. Dafür können Lichtquellen mit begrenztem Spektrum (LEDs, Halbleiterlaser) und ein für den ausgesuchten Spektralbereich hinreichend empfindlicher Photodetektor (Halbleiterphotodetektor, Photomultiplier) verwendet werden. Alternativ kann eine Weißlichtquelle und ein spektrometrisch auflösend messender Detektor eingesetzt werden. Ziel der Messung ist die Erfassung von Lichtschwächungswerten (optische Dichte des Gewebes) bei einzelnen interessierenden Wellenlängen im Zeitverlauf. Diese ergibt sich aus der BeziehungA spectrometric measurement is advantageous for the optical measurement of swelling conditions and the differentiation of swelling causes. Light sources with a limited spectrum (LEDs, semiconductor lasers) and a photodetector that is sufficiently sensitive to the selected spectral range (semiconductor photodetector, photomultiplier) can be used for this. Alternatively, a white light source and a spectrometrically resolving detector can be used. The aim of the measurement is the acquisition of light attenuation values (optical density of the tissue) at individual wavelengths of interest over time. This results from the relationship
wobei ls(λ,t) die am Sendeelement abgestrahlte Lichtintensität und lü(λ,t) die am Empfangselement ankommende Lichtintensität bei der Wellenlänge λ und zum Zeitpunkt t bezeichnen. Die Extinktion E(λ,t) ist im allgemeinen eine Funktion der Lichtstreuung und der Lichtabsorption in Gewebe und liefert damit einen Messwert für die geometrische und optische Veränderung des Gewebes. Durch Differenzbildung E(λι,t)-E(λ2,t) bei zwei Wellenlängen kann ein Relativmaß der Änderung bestimmt werden, welches das Verhältnis der Volumenänderungswerte einzelner Gewebekonstituenten wiedergibt und weitestgehend von geometrischen Effekten befreit ist. So ist beispielsweise bei Verwendung einer hämoglobinsensitiven Wellenlänge von λι=800nm und einer H2O-sensitiven Wellenlänge von λ2=970nm das Verhältnis zwischen Blut- und Gewebewasserzunahme darstellbar. Weiterhin ist es durch Anwendung spezieller optischer Messtechniken möglich, Streu- und Absorptionseigenschaften des Gewebes getrennt zu bestimmen. Dazu sind Photonenlaufzeitmessungen mit Hilfe einer Hochfrequenzmodulationstechnik (Intensitätsmodulation der Lichtquelle/n und Amplituden- und Phasenmessung des Empfängersignals) bzw. einer Pulslasertechnik (Applikation kurzer Laserpulse und zeitaufgelöste Messung des Empfängersignals) erforderlich. Diese Messmethoden sowie dazugehörige mathematische Verfahren zur Bestimmung optischer Parameter aus solchen Messdaten sind Stand von Wissenschaft und Technik (z. B. Sevick et al.: „Quantitation of time- and frequency resolved optical spectra for the determination of tissue oxygenation", Anal. Biochem. 195, 330-51 , 1991 ; Patterson et al., "Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties", Appl. Opt, 28, 2331-36, 1989).where ls (λ, t) denote the light intensity emitted at the transmitting element and lü (λ, t) denote the light intensity arriving at the receiving element at the wavelength λ and at time t. The extinction E (λ, t) is generally a function of light scattering and light absorption in tissue and thus provides a measurement for the geometric and optical change in the tissue. By forming the difference E (λι, t) -E (λ 2 , t) at two wavelengths, a relative measure of the change can be determined, which reflects the ratio of the volume change values of individual tissue constituents and is largely free of geometric effects. For example, when using a hemoglobin-sensitive wavelength of λι = 800nm and an H 2 O-sensitive wavelength of λ 2 = 970nm, the relationship between blood and tissue water gain can be represented. Furthermore, by using special optical measurement techniques, it is possible to determine the scattering and absorption properties of the tissue separately. This requires photon transit time measurements using a high-frequency modulation technique (intensity modulation of the light source (s) and amplitude and phase measurement of the receiver signal) or a pulse laser technique (application of short laser pulses and time-resolved measurement of the receiver signal). These measurement methods as well as the associated mathematical methods for determining optical parameters such measurement data are state of the art in science and technology (e.g. Sevick et al .: "Quantitation of time and frequency resolved optical spectra for the determination of tissue oxygenation", Anal. Biochem. 195, 330-51, 1991; Patterson et al., "Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties", Appl. Opt, 28, 2331-36, 1989).
Der Ablauf einer Messung soll hier am Beispiel einer provozierten allergischen Reaktion (Provokationstest) erläutert werden.The course of a measurement is to be explained here using the example of a provoked allergic reaction (provocation test).
Nach Vorbereitung der zu untersuchenden Person wird das Applikationsteil auf dem Nasenrücken in der Nähe der Nasenwurzel so fixiert, dass sich die optischen Sende- und Empfangselemente am Gewebe gegenüberstehen und die optische Strahlung möglichst viel schwellfähiges Gewebe im Inneren der Nase durchdringt (Fig. 5). Danach wird ein möglichst optimales photometrisches Signal mit Hilfe einer manuellen, automatischen oder halbautomatischen Einstellung von Quellintensität(en) und/oder Detektorempfindlichkeit in einen für die Messung geeigneten Bereich mittels optomechanischer, elektronischer und/oder softwaretechnischer Möglichkeiten eingestellt. Die Datenerfassung wird dann manuell durch den Bediener gestartet. Gesteuert durch den grundgerätinternen Controller 17 erfolgt ein wiederholtes sequentielles Schalten der Strahlungsquellen durch die Senderelektronik 15 und zeitgleich die Erfassung der Detektormesswerte durch die Empfängerelektronik 16. Durch getrennte Messung des Umgebungslichtes (Dunkelsignal) bei ausgeschalteten Lichtquellen oder alternativ durch eine Messung des AC-Anteils eines genügend hoch modulierten Lichtsignals der Lichtquellen wird dafür gesorgt, dass nur das durch die Lichtquellen erzeugte Licht und nicht das in die Messvorrichtung eventuell einfallende Umgebungslicht gemessen wird.After preparation of the person to be examined, the application part is fixed on the bridge of the nose near the root of the nose so that the optical transmission and reception elements on the tissue face each other and the optical radiation penetrates as much swellable tissue as possible inside the nose (Fig. 5). Then a photometric signal that is as optimal as possible is set with the aid of manual, automatic or semi-automatic adjustment of source intensity (s) and / or detector sensitivity in a range suitable for the measurement by means of optomechanical, electronic and / or software technology options. The data acquisition is then started manually by the operator. Controlled by the controller 17 internal to the basic unit, there is a repeated sequential switching of the radiation sources by the transmitter electronics 15 and, at the same time, the detection of the detector measured values by the receiver electronics 16. By separate measurement of the ambient light (dark signal) when the light sources are switched off, or alternatively by a measurement of the AC portion of a sufficient Highly modulated light signal from the light sources ensures that only the light generated by the light sources and not the ambient light that may be incident on the measuring device is measured.
In der Fig. 6 sind schematisch Extinktionsmesswerte im Verlauf einer Schwellung dargestellt. Die spektralen Lichtschwächungswerte im unprovozierten Zustand stellen die Grundlinie der Messung dar. Ist diese in einem Zeitfenster von 1 bis 2 Minuten erfasst, wird ein allergener Stoff durch Zerstäuben in eine oder beide Nasenhöhle(n) verabreicht und der Messzeitpunkt, z. B. durch Betätigung eines Fußschalters zum Verabreichungszeitpunkt tp, aufgezeichet. Bei einer allergischen Reaktion beginnt dann eine Schwellung des Nasengewebes, welche eine nachweisbare Zunahme der spektralen Extinktion bewirkt. In Fig. 6 sind spektrale Extinktionswerte dargestellt, welche zur besseren Verständlichkeit am Anfangszeitpunkt tp normiert wurden. Die Schwellung erreicht zum Zeitpunkt tε einen stationären Zustand, an dem keine weitere Schwellung mehr nachweisbar ist. Erst nach einer Zeit t»tE-tp klingt die Schwellung wieder ab. Diagnostisch verwertbare Informationen sind aus dem Zeitverlauf der spektralen Extinktionswerte ableitbar. Zu diesen zählen insbesondere:FIG. 6 schematically shows absorbance measurements in the course of a swelling. The spectral light attenuation values in the unprovoked state represent the baseline of the measurement. If this is recorded in a time window of 1 to 2 minutes, an allergenic substance is administered by atomization into one or both nasal cavities and the time of measurement, e.g. B. recorded by pressing a foot switch at the time of administration tp. With an allergic reaction, swelling of the nasal tissue then begins, which causes a demonstrable increase in the spectral absorbance. 6 shows spectral extinction values, which were standardized at the start time tp for better comprehensibility. At the time tε, the swelling reaches a steady state at which no further swelling can be detected. The swelling subsides only after a time t »t E -tp. Information that can be used diagnostically can be derived from the time course of the spectral extinction values. These include in particular:
- der Anstieg ΔE(λ)=E(λ,tE)-E(λ,tP) der Extinktion für eine Wellenlänge als Maß für die Stärke der Schwellung; die Extinktionswertedifferenz ΔE(λι)- ΔE(λ2) bei verschiedenen Wellenlängen als Maß für die Zunahme der Volumenanteile verschiedener Gewebekonstituenten relativ zueinander; die zeitliche Differenz der Reaktion vom Provokationszeitpunkt bis zum stationären Endzustand als Maß für die Schwellungsgeschwindigkeit sowie die Form der Kurven E(λ,t) als Indikator für den physiologischen Ablauf der Schwellung. the increase ΔE (λ) = E (λ, t E ) -E (λ, t P ) of the absorbance for a wavelength as a measure of the intensity of the swelling; the extinction value difference ΔE (λι) - ΔE (λ 2 ) at different wavelengths as a measure of the increase in the volume fractions of different tissue constituents relative to one another; the time difference the reaction from the time of provocation to the final stationary state as a measure of the swelling rate and the shape of the curves E (λ, t) as an indicator of the physiological course of the swelling.
BezugszeichβnlisteBezugszeichβnliste
1 - Applikationsteil1 - Applied part
2 - optisches Sβndβelβmβnt2 - Optical remote control
3 - optisches Empfangsβlement3 - Optical reception element
4 - stromführendes Kabel4 - live cable
5 - optisches Umlβnkθlθment - optische Verbindung zum Sendθθlement5 - optical Umlβnkθlθment - optical connection to the Sendθθlement
7 - optische Verbindung zum Empfängerelement7 - optical connection to the receiver element
8 - Stirnträgerband8 - browband
9 - Kugelgelenk9 - ball joint
10 - Befestigungsbügel10 - mounting bracket
11 - Durchstrahlungskanal11 - transmission channel
12 - Grundgerät12 - basic device
13 - Uchterzβugungskomponentβn13 - Generating Components
14 - Lichtdetektionskomponente14 - Light detection component
15 - Senderelektronik15 - transmitter electronics
16 - Empfangerelektronik16 - Receiver electronics
17 - Controller17 - controller
18 - optisches Element 18 - optical element
Claims
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10215212 | 2002-04-02 | ||
| DE10215212A DE10215212B4 (en) | 2002-04-02 | 2002-04-02 | Arrangement for the optical measurement of swelling conditions of the nose |
| PCT/DE2003/001146 WO2003082089A1 (en) | 2002-04-02 | 2003-04-01 | Method and system for optically measuring swelling of the nose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1492447A1 true EP1492447A1 (en) | 2005-01-05 |
Family
ID=28458613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03722269A Withdrawn EP1492447A1 (en) | 2002-04-02 | 2003-04-01 | Method and system for optically measuring swelling of the nose |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1492447A1 (en) |
| JP (1) | JP2005521451A (en) |
| CN (1) | CN1326488C (en) |
| AU (1) | AU2003229517A1 (en) |
| CA (1) | CA2480970A1 (en) |
| DE (1) | DE10215212B4 (en) |
| WO (1) | WO2003082089A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10257371A1 (en) * | 2002-12-06 | 2004-06-24 | Technische Universität Dresden | Arrangement to be used for examining swelling of nasal mucosa when exposed to particular substances |
| WO2010050170A1 (en) * | 2008-10-30 | 2010-05-06 | 株式会社日立製作所 | Organism light measuring device |
| JP6086418B2 (en) * | 2012-03-05 | 2017-03-01 | 日本光電工業株式会社 | Airway adapter and biological information acquisition system |
| KR101399446B1 (en) * | 2012-09-24 | 2014-05-28 | 김승제 | Laser beam basking apparatus for rhinitis treatment |
| CN103549937B (en) * | 2013-11-07 | 2015-03-11 | 中国医科大学附属第一医院 | Tissue-swelling measurement instrument and control method thereof |
| DE102018000995A1 (en) | 2018-02-08 | 2019-08-08 | Sutter Medizintechnik Gmbh | Arrangement for the quantitative measurement of the elastic deformation of the lateral nasal wall (elastometry) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2310315A (en) * | 1940-10-07 | 1943-02-09 | Dow Chemical Co | Sodium sulphate flotation |
| US4830014A (en) * | 1983-05-11 | 1989-05-16 | Nellcor Incorporated | Sensor having cutaneous conformance |
| WO1997036538A1 (en) * | 1996-04-01 | 1997-10-09 | Kontron Instruments Ag | Detection of parasitic signals during pulsoxymetric measurement |
| US5846188A (en) * | 1997-01-17 | 1998-12-08 | Palti; Yoram | Sensor utilizing living muscle cells |
| WO2000000080A1 (en) * | 1998-06-26 | 2000-01-06 | Triphase Medical Ltd. | A device for evaluating blood system properties |
| US6343224B1 (en) * | 1998-10-15 | 2002-01-29 | Sensidyne, Inc. | Reusable pulse oximeter probe and disposable bandage apparatus |
-
2002
- 2002-04-02 DE DE10215212A patent/DE10215212B4/en not_active Expired - Fee Related
-
2003
- 2003-04-01 AU AU2003229517A patent/AU2003229517A1/en not_active Abandoned
- 2003-04-01 JP JP2003579638A patent/JP2005521451A/en active Pending
- 2003-04-01 CA CA002480970A patent/CA2480970A1/en not_active Abandoned
- 2003-04-01 CN CNB038078422A patent/CN1326488C/en not_active Expired - Fee Related
- 2003-04-01 WO PCT/DE2003/001146 patent/WO2003082089A1/en not_active Ceased
- 2003-04-01 EP EP03722269A patent/EP1492447A1/en not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO03082089A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003082089A1 (en) | 2003-10-09 |
| CA2480970A1 (en) | 2003-10-09 |
| DE10215212B4 (en) | 2004-09-23 |
| DE10215212A1 (en) | 2003-10-30 |
| CN1646054A (en) | 2005-07-27 |
| JP2005521451A (en) | 2005-07-21 |
| CN1326488C (en) | 2007-07-18 |
| AU2003229517A1 (en) | 2003-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69308438T2 (en) | Method and device for non-invasive measurement of glucose | |
| DE69632320T2 (en) | ANALYSIS OF BLOOD COMPONENTS CONTROLLED BY ACTIVE IMPULSES | |
| DE69024490T2 (en) | DEVICE FOR MONITORING BODY FUNCTIONS | |
| DE69518434T2 (en) | LOW-NOISE OPTICAL SENSOR | |
| DE69613902T2 (en) | Probe connector with measuring laser diode | |
| DE19840452B4 (en) | Method and device for non-invasive measurement of blood component concentrations | |
| DE69229554T2 (en) | HEMOGLOBIN MEASUREMENT FOR DETERMINING THE METABOLISM SIZE OF A PERSON | |
| DE2049716C3 (en) | Method and device for measuring absorption in blood | |
| DE69033104T2 (en) | Method and device for the non-invasive measurement of the content of a chemical substance in the blood | |
| DE69635228T2 (en) | DEVICE FOR PULSE OXIMETRY THROUGH LASER DIODE BY MULTIFASER OPTICAL CABLES AND DISPOSABLE FIBER OPTIC PROBE | |
| DE68923941T2 (en) | Method and device for measuring the properties of a substance by means of light scattering. | |
| DE102016109694B4 (en) | SENSOR DEVICE | |
| DE112004002988T5 (en) | Instrument for non-invasive measurement of blood sugar level | |
| EP0030610B1 (en) | Method and device for quantitative determination of optically active substances | |
| EP0555645A1 (en) | Device for detecting dental caries | |
| DE4243142A1 (en) | Device for in-vivo determination of an optical property of the aqueous humor of the eye | |
| JP2002500908A (en) | Tissue modulation apparatus and method | |
| DE602004001794T2 (en) | Method and device for in vitro or in vivo measurement of the concentration of a substance | |
| US7244027B2 (en) | Perimeter | |
| EP2218395A2 (en) | Device and method for determining at least one vital parameter of a person; vital parameter determination system | |
| EP1492447A1 (en) | Method and system for optically measuring swelling of the nose | |
| Gupta et al. | Jaundice prediction through non-invasive techniques: Issues and challenges | |
| DE4419489A1 (en) | Device for measuring the pupil reaction of an eye | |
| DE20209441U1 (en) | Device for the detection of bacterial infection on teeth | |
| DE4410690C1 (en) | Test system for spectrometric examination of structures in layers of bodies e.g. eyes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20041027 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| 17Q | First examination report despatched |
Effective date: 20071221 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20090103 |